XDx, LabCorp sign new collaboration, license agreement
The companies will collaborate in marker discovery and LabCorp will develop and commercialize a diagnostic test to predict flares of systemic lupus erythematosus (SLE). Financial terms of the
The companies will collaborate in marker discovery and LabCorp will develop and commercialize a diagnostic test to predict flares of systemic lupus erythematosus (SLE). Financial terms of the
The generic version of Boehringer Ingelheim’s Viramune is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection. Mylan CEO Heather Bresch said the launch of Nevirapine Tablets, 200mg,
Alnylam has received world-wide, non-exclusive license to the Baulcombe patent from PBL for use in the field of human therapeutics. Both the companies have kept the financial terms
The API Manager is an essential component of any Quality by Design initiative, providing the necessary automation, integration and database reporting functionality that ensure all multi-variety data are
The extended WMS solution offers traceability and order tracking features based on expiration date, serial number, and batch number tracking, and also provides reverse logistics capabilities to track
The companies have already partnered in developing a synthetic pathway for ML7, manufacturing the first non-GMP batches and devising associated analytical methods. The process optimization phase to facilitate
Imvamune is a MVA-BN (a strain of the Modified Vaccinia Ankara) based third-generation smallpox vaccine candidate that has been shown to be well tolerated in healthy subjects in
ThermoGenesis chief executive officer Matthew Plavan said the approval is an important step in the company’s strategy to expand the geographic reach of its products. "The number of
In the study, which estimated Amitiza (lubiprostone) for OBD in patients with chronic, non-cancer pain, excluding those taking methadone, the investigation compound met its primary endpoint and was
The basal insulin analog is approved for type 1 diabetes patients from age two through adulthood and adult patients with type 2 diabetes. Pediatric Diabetes Editor-in-Chief Mark Sperling